πŸ‡ΊπŸ‡Έ FDA
Patent

US 7183323

Sodium channel modulators

granted A61PA61P25/02

Quick answer

US patent 7183323 (Sodium channel modulators) held by Theravance, Inc. expires Mon Feb 22 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Theravance, Inc.
Grant date
Tue Feb 27 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 22 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61P, A61P25/02